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Abstract
Purpose There is currently no true macrophage cell line and in vitro experiments requiring these cells currently require 
mitogenic stimulation of a macrophage precursor cell line (THP-1) or ex vivo maturation of circulating primary monocytes. 
In this study, we characterise a human macrophage cell line, derived from THP-1 cells, and compare its phenotype to the 
THP-1 cells.
Methods THP-1 cells with and without mitogenic stimulation were compared to the newly derived macrophage-like cell line 
(Daisy) using microscopy, flow cytometry, phagocytosis assays, antigen binding assays and gene microarrays.
Results We show that the cell line grows predominantly in an adherent monolayer. A panel of antibodies were chosen to 
investigate the cell surface phenotype of these cells using flow cytometry. Daisy cells expressed more CD11c, CD80, CD163, 
CD169 and CD206, but less CD14 and CD11b compared with mitogen-stimulated THP-1 cells. Unlike stimulated THP-1 
cells which were barely able to bind immune complexes, Daisy cells showed large amounts of immune complex binding. 
Finally, although not statistically significant, the phagocytic ability of Daisy cells was greater than mitogen-stimulated THP-1 
cells, suggesting that the cell line is more similar to mature macrophages.
Conclusions The observed phenotype suggests that Daisy cells are a good model of human macrophages with a phenotype 
similar to human alveolar macrophages.
Keywords Macrophage · Alveolar · THP-1 · Daisy
Introduction
Macrophages are the predominant mononuclear phagocytes 
of the innate immune system and have a fundamental role 
in inflammatory processes throughout the body. Upon acti-
vation, macrophages are capable of eliciting a specialised 
immune response, the primary function of which is dictated 
by the stimulus and the environment in which the mac-
rophage resides [1].
In vitro experiments requiring human macrophages use 
mitogenic (e.g. PMA) stimulation of a macrophage precur-
sor cell line (e.g. THP-1 or U937), cells extracted during 
broncho-alveolar lavage (BAL) or ex vivo maturation of 
circulating primary monocytes. PMA stimulation activates 
protein kinase C resulting in phosphorylation of downstream 
signalling molecules [2]. This prolonged signalling activa-
tion regulates gene expression in a manner not comparable 
to human monocyte-derived macrophages [3].
The THP-1 cells are a human monocytic leukaemia cell 
line initially isolated by Tsuchiya et al. [4]. These cells grow 
in suspension and resemble human monocytes in morphol-
ogy, secretory products, and membrane antigen expression 
[5]. A recent study by Forrester et al. has extensively char-
acterised the cell surface markers of THP-1 monocytes and 
compared them to PMA-differentiated THP-1 macrophage 
cells [6]. Here we have derived a unique sub-clone of THP-1 
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cells which are capable of spontaneous and perpetual dif-
ferentiation into alveolar macrophage-like cells without the 
need for PMA differentiation. This cell line, termed ‘Daisy’, 
was spontaneously derived [7] from a THP-1 clone sent as 
a gift. Upon initial culture, it was clear that they were not 
typical THP-1 cells since a large proportion of these cells 
were adherent. This phenomenon is not seen with THP-1 
cells which normally grow in suspension. For this reason, 
we extensively characterised the new ‘Daisy’ sub-clone to 
investigate whether it retained key phenotypic and transcrip-
tional features associated with mature macrophages, native 
THP-1 cells and/ or PMA-stimulated THP-1 cells.
Materials and Methods
All cells were maintained in RPMI 1640 media (supple-
mented with 10% v/v Foetal Bovine Serum and 100 U/ml 
Penicillin and 0.1 mg/ml Streptomycin (Gibco, Paisley, 
UK)). THP-1 cells were differentiated using PMA (50 nM 
for 24 h, then 24 h PMA free), as described previously [8].
Microscopy
Cells cultured in T25 flasks were visualised on an Olympus 
CK2 inverted microscope using phase contrast at 20 × mag-
nification and captured on an Olympus C-5060 wide zoom 
digital camera. Transmission electron microscopy (TEM) 
was performed as described previously [8]. Briefly, cells 
were fixed (2.5% iso-osmotic glutaraldehyde in sodium 
cacodylate buffer, pH 7.3), post fixed (1% osmium tetroxide) 
then stained (1% uranyl acetate) before ethanol and propyl-
ene oxide dehydration. EPON resin embedded cells were 
then sectioned (Leitz UC6 ultra microtome) and visualised 
using a Jeol 2010 TEM.
Mycoplasma Testing
THP-1 and Daisy cells were tested for mycoplasma infection 
using a MycoFluor™ mycoplasma detection kit (Molecular 
Probes, Paisley, UK) and the MycoProbe™ detection kit 
(R&D, Abingdon, UK) as per the manufacturers’ protocol.
Assessment of Phagocytosis and Lipid Uptake
PMA/THP-1 and Daisy cells were incubated with zymosan 
beads and differentially stained, as described previously [8].
The ability of PMA/THP-1 and Daisy cells to take up 
unmodified lipid was assessed. Cells were incubated with 
10% v/v Calogen (Nutricia, Wiltshire, UK) lipid rich liquid 
meal for a sub-optimal treatment time of 4 h before washing, 
staining with Oil Red O (ORO) and scoring according to the 
lipid-laden index (LLI) Colombo and Hallberg method [9]. 
Briefly, 100 cells were scored per experimental condition, 
assigning a value of 0–4 depending on the degree of lipid 
staining. The scores for the 100 cells were added to give the 
LLI. Cells from each well of a 24-well plate were scored 
in three independent experiments. The mean of the scores 
was then calculated and an unpaired, 2-tailed t-test was per-
formed on the mean of the scores, for samples with unequal 
variance using Microsoft Excel 2010.
Assessment of Immune Complex Binding
PMA/THP1 and Daisy cells were assessed for their ability 
to bind immune complexes. Fluorescent-labelled immune 
complexes were generated in-house as described by Hart 
et al. [10]. Mouse monoclonal FITC-conjugated anti-biotin 
antibody (170 ng/ml) was added to biotin labelled bovine 
serum albumin (BSA) (500 ng/ml) and the solution was 
placed on ice, in the dark (30 min) (BXB100).
Cells (1 × 105) were then incubated with the fluorescent 
immune complex (BXB100) (100 ng/ml) for 30 min at 4 °C 
with gentle agitation. Cells were washed and re-suspended in 
FACSFlow Buffer (BD Biosciences) and analysed on a FAC-
SAria II™ flow cytometer (BD Biosciences), running BD 
FACSDiva software (v6.1.3), counting 10,000 cells per sam-
ple. An unpaired, 2-tailed t-test was performed on the mean 
fluorescence, on separate cell combinations for samples with 
unequal variance using Microsoft Excel 2010 software.
Cell Surface Immunophenotype
Cell surface Immunophenotyping of THP-1 cells, PMA/
THP-1 cells and Daisy cells was assessed by flow cytom-
etry as described previously [8] using a BD FACSAria II 
flow cytometer or using a BD Accuri C6 Flow cytometer 
and analysed using Flow-Jo software (v10). All antibod-
ies were unconjugated mouse monoclonal (AbD Serotec, 
Oxford, UK) except CD32 [11]. A FITC-conjugated rab-
bit anti-mouse secondary was used for detection. Data were 
analysed with SPSS software (v19) and statistically signifi-
cant differences in cell surface molecule expression were 
calculated. An independent samples Kruskal–Wallis test 
highlighted significant differences across all three cell types. 
Subsequent post hoc testing using Mann–Whitney tests then 
identified specific differences in expression.
Gene Microarray
THP-1, PMA/THP-1 and Daisy cells were analysed for 
gene expression profiles, as described previously [8]. 
mRNA samples extracted using a NucleoSpin RNA II kit 
(Macherey–Nagel) were analysed using an Agilent G4851A 
SurePrint G3 Hmn GE 8 × 60 K Microarray on an Agilent 
G2505C microarray scanner at the University of York, 
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Bioscience Technology Facility. Data were normalised 
by converting all the data values to log values (to base 2). 
Percentile shift normalisation and median baselining was 
performed on the data. A t-test was performed on each com-
parison group for each gene, and was corrected for multiple 
testing using the Benjamini–Hochberg FDR method. Prin-
cipal component analysis (PCA) was performed on log2-
transformed data using R v.3.6.1 [7]. Hierarchal clustering 
and Venn diagrams were based on differentially expressed 
genes above twofold different and over 5% alpha level sig-
nificance. For hierarchal clustering, data were scaled, and 
the top 5000 most variable genes were clustered via Euclid-
ian distance and Ward D2′s method within R v.3.6.1 [7]. 
Functional annotation was performed using the Database 
for Annotation, Visualisation and Integrated Discovery 
(DAVID) v.6.8 [12], with top annotations plotted against 
Benjamini–Hochberg FDR P value.
Results
Morphology of Daisy versus THP‑1 cells by Light 
Microscopy
The morphology of the Daisy THP-1 sub-clone was com-
pared with THP-1 and PMA/THP-1 cells by light micros-
copy (Fig. 1). THP-1 cells (Fig. 1a) grew predominantly in 
suspension and were not clumped with a small proportion of 
cells (<5%) very loosely adhering to the bottom of the tis-
sue culture flask, becoming detached upon gentle agitation.
PMA/THP-1 (Fig.  1b) appeared slightly larger than 
THP-1 cells and were firmly adherent to the culture plate. 
These cells were clumped together and were flattened with 
some pseudopodia.
Daisy cells (Fig. 1c) appeared distinct. Although some 
cells grew in suspension and resembled native THP-1 
cells, the majority formed an adherent cell monolayer. The 
adherent cells appeared larger and more flattened than the 
suspended cells, but did not clump together and show long 
pseudopodia, and in some cases appearing as long stretched 
out cells. When separated from adherent Daisy cells, non-
adherent cells were capable of adhering to the new flask, 
indicative of a single population of cells. This Daisy phe-
notype appeared stable and has persisted for more than two 
years in two different research laboratories. All assays were 
done on the adherent population of cells.
Mycoplasma Screening
Given the unexpected differences of the Daisy cells, Myco-
plasma infection was screened using two separate meth-
ods. Neither the MycoFluor™ Mycoplasma Detection Kit 
(Molecular Probes) nor the colorimetric MycoProbe™ 
(R&D, Abingdon, UK) detection kit showed any Myco-
plasma infection in the Daisy cells (data not shown).
Morphology of Daisy versus PMA/THP‑1 cells by TEM
Using TEM, Daisy and PMA/THP-1 cells appeared sim-
ilar in size and shape, both with crescent nuclei (Fig. 2). 
The nuclei of the PMA/THP-1 cells (Fig. 2a) showed large 
areas of loosely coiled euchromatin, appearing as light grey 
areas, whilst Daisy cells (Fig. 2b) showed a high degree of 
tightly coiled heterochromatin, appearing as dark grey areas. 
The membrane of PMA/THP-1 cells showed some ruffling, 
whilst the Daisy cells showed a high degree of ruffling and 
pseudopodia. Both cells showed round vesicular inclusions 
within the cytoplasm and cholesterol clefts; however, they 
appeared to a higher degree in Daisy cells.
Assessment of Phagocytosis
The phagocytic ability of the cells was investigated by 
incubating with zymosan, differentially staining, and 
Fig. 1  Morphology of daisy cells by light microscopy. THP-1 cells 
(a) appear predominantly suspended with some loosely adherent 
flattened cells making up no more than 5% of the total cells. When 
treated with 50  nM PMA for 24  h (b) and allowed 24  h recovery, 
THP-1 cells become adherent forming ‘clumps’ with increased cyto-
plasm and inhibited mitotic growth. Daisy cells (c) originally thought 
to be THP-1 cells show predominantly strongly adherent cells with a 
flattened morphology and pseudopodia without ‘clumping’
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using a phagocytic index (Fig. 3). Whilst PMA/THP-1 
cells showed some phagocytosis (Fig. 3b), a large number 
of cells showed no phagocytosis. Daisy cells showed a 
large number of cells containing many zymosan particles, 
although variation across three separate experiments was 
high (Fig. 3d) and no statistically significant difference 
was detected (Fig. 3e). The experiment shown in Fig. 3d 
demonstrates Daisy cells which have phagocytosed many 
particles represented by the large number of white dots in 
the cytoplasm.
Assessment of Lipid Uptake
Lipid uptake by PMA/THP-1 cells and Daisy cells was 
detected with ORO. Slides were scored and a mean was 
calculated across 3 × 24 slides for each cell type (Fig. 4). 
Both cell types accumulated lipid after 4  h with the 
majority of cells showing between 50–75% lipid staining 
(Fig. 4b and d). No statistically significant difference was 
detected between the two cell types (Fig. 4e).
Fig. 2  Morphology of Daisy cells by transmission electron micros-
copy. THP-1 cells (Ai and Aii) treated with PMA (50  nM; 24  h) 
appear approximately 14 µm in diameter with a large crescent-shaped 
nucleus containing euchromatin which is predominant. The cell mem-
brane is slightly ruffled and there appears to be a number of vesicu-
lar inclusions and cholesterol clefts. Daisy cells (Bi and Bii) appear 
similar in size, shape and granularity; however, they show a higher 
proportion of heterochromatin, pseudopodia and vesicular inclusions. 
Pictures are representative images from 10 different cells for each cell 
type
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Fig. 3  Assessment of Phagocytic capability of THP-1 and Daisy 
cells. PMA (50  nM; 24  h)-treated THP-1 cells (a) were differen-
tially stained and compared to (b) THP-1 cells treated with PMA and 
zymosan (1  ng/ml; 1  h). c Untreated Daisy cells were also stained 
and compared with (d) Daisy cells treated with zymosan. Zymosan 
treated cells show phagocytosis of zymosan particles appearing as 
small purple dots surrounded by a white ring, approximately 3 µm in 
diameter at 40X magnification, contained within the cell cytoplasm. 
A phagocytic index was calculated (graph, right) by counting the 
number of zymosan particles within the cytoplasm of 100 cells and 
dividing this by 100 to give an average. Whilst THP-1 cells showed 
some phagocytosis, Daisy cells showed a marked, though not signifi-
cant, increase in phagocytosis by comparison
Fig. 4  Assessment of lipid uptake of THP-1 and Daisy cells. PMA 
(50  nM; 24  h) treated THP-1 cells (a) were stained with ORO and 
hematoxylin and compared to cells treated with 10% v/v Calogen 
(b), a high fat liquid meal containing sunflower and canola oil, for 
4 h. Untreated Daisy cells (c) were also stained and compared with 
Calogen treated cells (d). Slides were then scored and a mean was 
calculated across 3 × 24 slides for each cell type. Statistical analysis 
showed no significant difference in the amount of lipid accumulation 
between the two cell types
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Immune Complex Binding Capacity
The ability of PMA/THP-1 and Daisy cells to bind immune 
complexes was compared using flow cytometry (Fig. 5). 
THP-1 and PMA/THP-1 cells bound very little immune 
complex, with mean fluorescence between 36–110 AU. 
Statistically no difference was seen between these two cell 
types. However, Daisy cells showed very high, statisti-
cally significant immune complex binding in the region of 
1030–4010 AU (p = 0.02).
Cell Surface Immunophenotype
Cell surface immunophenotype of THP-1, PMA/THP-1 and 
Daisy cells was compared using flow cytometry to assess 
expression levels of key markers (Fig. 6). All three cell types 
showed differing expression profiles. PMA/THP-1 cells 
showed significant increases in CD14, CD11b and CD36 
with decreased CD32 expression compared with untreated 
THP-1 cells. Daisy cells showed decreased CD14 and 
CD11b with increased CD80, CD163 and CD206 expres-
sion compared with PMA/THP-1 cells.
We also observed expression of CD11c and CD169 in 
the Daisy cells but no significant expression of CX3CR1 or 
CSF1R (Fig. 6).
Gene Microarray Data Analysis
The magnitude of genetic difference between Daisy and 
THP-1 cells with or without PMA stimulation was analysed 
using an Agilent microarray system. Microarray data have 
been deposited in the ArrayExpress database at EMBL-
EBI (www.ebi.ac.uk/array expre ss) under accession number 
E-MTAB- 7169 and E-MTAB-4153. We have previously 
reported the change in gene expression in PMA/THP-1 
compared to untreated THP-1 cells [8]. The difference in 
gene expression between Daisy and THP-1 or PMA/THP-1 
cells was considerable (Fig. 7 a and b). 23,962 genes were 
upregulated and 3537 genes were downregulated in Daisy 
cells compared to both THP-1 cells and PMA/THP-1 cells. 
Smaller differences were observed in THP-1 comparison 
groups, where a total of 1566 genes were upregulated and 
98 genes were downregulated in THP-1 cells versus PMA/
THP-1 cells.
The differences between THP-1 and Daisy cells were 
even more apparent via hierarchal clustering analysis, 
where Daisy cells cluster were entirely independent of 
THP-1 groups (Fig. 7c). However, differences are also 
shown between the THP-1 cells and PMA/THP-1 cells, 
which cluster uniquely as shown by the heat map and PCA 
(Fig. 7c–d). Finally, functional annotation analysis of dif-
ferentially expressed genes demonstrated over-represen-
tation of UniProtKB and gene ontology (GO) pathways 
associated with immune cells (Fig. 7e). For example, high 
enrichment was shown for inflammatory response, chem-
otaxis and cytokine in Daisy cells vs THP-1 cells. With 
respect to alternative splicing and polymorphisms, we 
note that these UniProtKB groups were significantly over-
represented in Daisy cells vs THP-1 cells. While there 
were major differences between Daisy and THP-1 cells, 
we noted numerous functionally relevant UniProtKB and 
GO groups that were altered between THP-1 and PMA/
THP-1 cells, including immunity, receptor and leukocyte 
migration (Fig. 7f).
Discussion
We have characterised a unique sub-clone of THP-1 cells 
capable of spontaneous perpetual differentiation into mac-
rophage-like cells termed ‘Daisy’. These cells are adherent 
and capable of phagocytosis of foreign material, lipid uptake 
and immune complex binding. They also express cell surface 
markers of human alveolar macrophages.
Morphologically, these cells are adherent in the absence 
of PMA stimulation, unlike THP-1 cells, indicating mac-
rophage maturation. TEM revealed that they have a simi-
lar structural morphology to PMA/THP-1 cells, comparing 
well with published images of human macrophages [13]. 
High levels of euchromatin were seen in PMA/THP-1 cells 
suggesting increased DNA transcription processing. PMA 
stimulation is potent and long lasting, which may mask any 
subsequent activity during in vitro experiments. Daisy cells, 
however, showed less loosely coiled chromatin indicating 
that they are in a ‘resting’ state which is advantageous in the 
experimental setting.
A fundamental role of mature macrophages is to phago-
cytose foreign and damaged self-material. Both Daisy and 
PMA/THP-1 cells were capable of phagocytosis, with more 
particle uptake observed with the Daisy cells. However, no 
significant difference was seen between the two cell types. 
Both cell types were also equally capable of lipid accumu-
lation, indicating cell maturity; macrophages are known to 
accumulate lipid in the airways [14] and diseases such as 
atherosclerosis.
The cells’ binding capacity was measured using immune 
complexes. Surprisingly, PMA/THP-1 cells were barely able 
to bind these particles despite expression of similar levels of 
all three IgG receptors (CD16, CD32 and CD64) to Daisy 
cells. Indeed, expression of a protein does not prove that it is 
functional, which may be the case here. This is in contrast to 
the work of Daigneault, et al. [15] who observed competent 
phagocytosis of opsonised latex beads by PMA/THP-1 cells. 
Daisy cells were able to bind large amounts of immune com-
plexes indicating a significant difference between the two 
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Fig. 5  Immune complex bind-
ing capacity. THP-1 cells, PMA 
treated THP-1 cells and Daisy 
cells were incubated with fluo-
rescently labelled BSA:Mouse 
IgG complex (BXB100) as a 
model for immune complexes. 
Representative pseudocolour 
plots displaying side scatter 
(SSC-A) and FITC fluorescence 
(FITC-A) of unstained controls 
(a, c and e) and following 
immune complex binding by 
THP-1, PMA/THP-1 and Daisy 
cells (b, d and f respectively). 
THP-1 cells (a and b), PMA 
treated THP-1 cells (c and 
d) and Daisy cells (e and f) 
are shown with appropri-
ate quadrants (Q1–Q4) set to 
negative controls in THP-1 
cells. Numbers shown in each 
quadrant represent percentage 
of cells. Q3 represents cells 
positive for the peptide. Plots 
are representative of n = 5. Bar 
chart representing the mean 
fluorescence with and without 
BXB100 treatment of THP-1, 
PMA treated THP-1 cells and 
Daisy cells (G). Significant to 
p = 0.02. Results are expressed 
as the mean ± SEM of five 
experiments
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cell types and may suggest functional protein or binding by 
a different mechanism in these cells, for example, through 
complement receptors.
For cell surface phenotype characterisation, a panel 
of antibodies were chosen indicating myeloid cell ori-
gin (CD11b, CD14 and absence of CD24), cell maturity 
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(CD16, CD23 and CD64), macrophage activation (CD163 
and CD206), expression of co-stimulatory molecules (CD80 
and CD86) and a known lipid receptor (CD36).
Daisy cells had lower CD11b, 14 and 32 expression than 
PMA/THP-1 cells, yet higher levels of CD36, 80, 163 and 
206. The phenotype of the alveolar macrophage (AM) is 
known to vary greatly; however, expression of CD163, 
CD36, CD11c, and CD206 along with a lack of CD11b and 
CX3CR1 is compatible with the AMs phenotype [16-19]. 
A recent study by Mitsi et al.showed that the majority of 
AMs expressed high levels of CD206 and CD86 which sup-
ports our Daisy AM-like phenotype [20]. AMs help main-
tain immunological homoeostasis and host defence, while 
interstitial macrophages (IMs) appear to have a regulatory 
function within the lungs [21]. Reports have demonstrated 
differences between AM and IM in the lung [21], which 
may be distinguished by their unique combination of sur-
face markers including CD206 [22]. The chemokine receptor 
CX3CR1, expressed in the mononuclear phagocyte system, 
including IM and alveolar DCs [23], is absent in AMs [24]. 
However, CD169 is absent in IM [25], but present in AM 
and in a new subset of CD169 + lung resident macrophages 
that are phenotypically and developmentally distinct from 
the AM or IM [26]. These can be clearly differentiated from 
AM as they are CD11c negative.
Daisy cells showed similar expression levels of CD11b, 
a major macrophage cell adhesion molecule, to THP-1 cells 
despite being adherent in contrast. Perhaps, CD11b then 
is not the major adherent molecule for these cells. Mature 
tissue macrophages downregulate CD11b and upregulate 
CD11c which could indicate a more mature macrophage 
phenotype of Daisy cells compared to PMA/THP-1 cells. 
Expression of the IgG receptors was similar across all cell 
types except THP-1 cells which showed higher expression 
of CD32. No CD24, the granulocyte adhesion molecule, 
was seen in any of the cells, which, coupled with CD14 
expression, confirms the myeloid origins of Daisy cells. 
This molecule is only expressed by cells of the monocyte/
macrophage lineage. A significant increase in CD36 was 
seen in PMA/THP-1 cells and Daisy cells. As expected, 
THP-1 cells showed no expression of markers of activation. 
PMA/THP-1 cells showed increased CD86, a co-stimulatory 
molecule required for anti-inflammatory T-cell differentia-
tion, expressed by human macrophages when “classically 
activated” [27]. Daisy cells, however, showed high CD80 
expression, a co-stimulatory molecule required for pro-
inflammatory T-cell differentiation. Daisy cells also showed 
expression of CD163 and CD206, characteristic of alter-
native anti-inflammatory activation [27] not expressed by 
THP-1 cells whether stimulated or not.
Our data for cell surface phenotyping of THP-1 and 
PMA/THP-1 cells corresponds well with those from a recent 
paper by Forrester et al.[6]. They also showed an increase in 
CD36 and CD14 expression in PMA/THP-1 cells compared 
to THP-1 cells and CD64 was seen in both cell types. In 
agreement with our data, they also showed that CD32 was 
expressed to a higher degree in THP-1 cells compared to 
the PMA treated cells. Finally, they also found that neither 
THP-1 nor PMA/THP-1 cells expressed CD206, supporting 
our findings [6].
Gene array analysis corresponded well to the flow cytom-
etry phenotyping results with increases in CD206 and 
CD80 gene expression seen in Daisy cells vs. THP-1 and 
PMA/THP-1 cells. In addition, Daisy cells had a decrease 
in CD11b and CD14 gene expression compared to PMA/
THP-1 cells. The array data also demonstrated that Daisy 
cells were transcriptomically distinct from THP-1 cells, 
clustering entirely independently to THP-1 cells and PMA-
stimulated THP-1 cells. A comparison between the tran-
scriptome of Daisy cells and native macrophages or AM 
would be interesting for a future study. A study by Martinez 
however profiled the gene expression changes of human 
monocytes and macrophages [28]. It is difficult to compare 
the two studies and Martinez focused on polarisation of the 
macrophages; however, we did see downregulation of CCR2 
and CX3CR1 genes in Daisy cells compared to THP-1 cells, 
indicative of mature macrophages [28].
Karyotyping of the Daisy cells versus the THP-1 cells 
was not done in this study. Investigations into the genomic 
aberrations of THP-1 cells has been performed in other stud-
ies and highlighted that these cells exist as a mixture of sub-
clones and that these populations of cells can vary between 
labs [29, 30]. In future studies, it would therefore be interest-
ing to determine whether the Daisy cells exist as a sub-clone 
of THP-1 cells due to genomic aberrations.
In conclusion, the genetically distinct Daisy cells display 
a macrophage-like morphology, function and phenotype. 
They are functionally mature and active in, most likely, an 
alternative fashion. These cells show markers of AMs, mak-
ing them the first human AM-like cell line available. Such 
a cell line offers advantages over AMs obtained through 
invasive procedures like BAL, which renders limited cell, 
subject to individual and disease variability [31, 32]. The 
Fig. 6  Representative histograms displaying selected markers on 
THP-1 cells, PMA treated THP-1 cells and Daisy cells. Levels of 
CD11b (a), CD14 (b), CD80 (c), CD36 (d), CD163 (e) and CD206 
(f) were quantified by FITC fluorescence on conjugated secondary 
antibodies and assessed by flow cytometry. Unstained negative con-
trols for THP-1 cells (white), PMA treated THP-1 cells (light grey) 
and Daisy cells (dark grey) are included. Staining for THP-1 cells 
(blue), PMA treated THP-1 cells (orange) and Daisy cells (red) 
are displayed. Histograms are representative of n = 5. (G) is a sum-
mary table comparing the phenotypes of the three cell preparations. 
Thresholds: − score equates to < the negative control (<100 fluores-
cence AU); + is fluorescence between 100 and 300 AU; +  + is fluores-
cence between 300 and 500 AU; +  +  + is fluorescence between 500 
and 700 AU and +  +  +  + is fluorescence above 700 AU
◂
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unique phenotype of AMs is determined by the lung envi-
ronment [17] where GM-CSF is crucial for their phenotypic 
determination [33]. The Daisy cells have potential utility for 
future studies with the ability to spontaneously replicate and 
differentiate, reducing the need for blood donation in human 
macrophage research and eliminating PMA cell signalling 
interference.
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